Showing results (131-140 of 190) with videos related to
Sort By:
Pageof 19
BJC Reports|August 18, 2025
Hidden costs and unmet supportive care needs among individuals with experience of breast cancer and their carers in the United KingdomSzeyi Ng, Lucy S Kilburn, Hilary Stobart, et al.Breast Cancer Research and Treatment|March 29, 2013
Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancerJohn M S Bartlett, Roger A'hern, Tammy Piper, et al.Histopathology|October 23, 2009
Histological grading of invasive breast carcinoma--a simplification of existing methods in a large conservation series with long-term follow-upJeremy St J Thomas, Gillian R Kerr, Wilma J L Jack, et al.Advances in Therapy|March 13, 2019
Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical StudiesJ Michael Dixon, David A Cameron, Laura M Arthur, et al.The Lancet. Oncology|August 10, 2024
Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trialLinda J Williams, Ian H Kunkler, Karen J Taylor, et al.Health Technology Assessment (Winchester, England)|August 18, 2025
Medical management and intervention (using neurosurgical resection or stereotactic radiosurgery) versus medical management alone for symptomatic brain cavernoma: the CARE pilot RCTRustam Al-Shahi Salman, Neil Kitchen, Laura Forsyth, et al.The Journal of Pathology|March 5, 2020
The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancerSteven Hayward, Mariam Gachehiladze, Nahla Badr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapyJohn M S Bartlett, Ian O Ellis, Mitch Dowsett, et al.JAMA Network Open|February 23, 2023
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint InhibitorsDaniel A Goldstein, Gary M Ginsberg, Dorit Hofnung-Gabbay, et al.The Journal of Pathology|March 21, 2012
Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as a driver of progressionMelanie Spears, Carrie A Cunningham, Karen J Taylor, et al.Pageof 19